Recalls / Active ingredient / Alteplase
Alteplase
2 FDA drug recalls involving the active ingredient “Alteplase”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-05-20 | Class II | Cathflo activase (ALTEPLASE), 2mg vials, Rx only, Genentech Inc., South San Francisco, CA 94080, NDC 50242-041 | Genentech, Inc. |
| 2021-03-15 | Class II | cathflo activase (ALTEPLASE) 2 mg Rx Only NDC 50242-041-64 Genentech | Cardinal Health Inc. |